Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Duration: September 30, 2009
to
January 24, 2020
General Issues: Health Issues , Medical/Disease Research/Clinical Labs , Medicare/Medicaid
Spending: about $1,420,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Agency for Healthcare Research & Quality (AHRQ), Defense - Dept of (DOD), Office of Personnel Management (OPM), Centers For Medicare and Medicaid Services (CMS), House of Representatives, Senate, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2020
BROYDRICK & ASSOCIATES terminated an engagement in which they represented Exact Sciences on Jan. 30, 2020.
Original Filing: 301130974.xml
4th Quarter, 2019
In Q4, BROYDRICK & ASSOCIATES did no lobbying for Exact Sciences . The report was filed on Jan. 16, 2020.
Original Filing: 301108140.xml
3rd Quarter, 2019
In Q3, BROYDRICK & ASSOCIATES did no lobbying for Exact Sciences . The report was filed on Oct. 15, 2019.
Original Filing: 301066004.xml
2nd Quarter, 2019
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences . The report was filed on July 18, 2019.
Original Filing: 301049959.xml
Lobbying Issues
Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
1st Quarter, 2019
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences . The report was filed on April 10, 2019.
Original Filing: 301024101.xml
Lobbying Issues
Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
4th Quarter, 2018
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on Jan. 16, 2019.
Original Filing: 301005952.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act. DEA Acceptance. VA Appropriations bill.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
3rd Quarter, 2018
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $70,000. The report was filed on Oct. 5, 2018.
Original Filing: 300983171.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act. DEA Acceptance. VA Appropriations bill.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
2nd Quarter, 2018
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on July 16, 2018.
Original Filing: 300965802.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act. DEA Acceptance. VA Appropriations bill.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
1st Quarter, 2018
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on April 16, 2018.
Original Filing: 300945482.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
4th Quarter, 2017
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $60,000. The report was filed on Jan. 17, 2018.
Original Filing: 300925937.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
3rd Quarter, 2017
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $60,000. The report was filed on Oct. 15, 2017.
Original Filing: 300904049.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act. DEA Acceptance.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA)
2nd Quarter, 2017
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on July 16, 2017.
Original Filing: 300885338.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Agency for Healthcare Research & Quality (AHRQ) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agency for Healthcare Research & Quality (AHRQ) Office of Personnel Management (OPM) Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $40,000. The report was filed on April 17, 2017.
Original Filing: 300866846.xml
Lobbying Issues
21st Century Cures project. USPSTF Approvals. American Healthcare Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Agency for Healthcare Research & Quality (AHRQ) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD)
Lobbying Issues
Legislation on cancer screening test process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agency for Healthcare Research & Quality (AHRQ) Office of Personnel Management (OPM) Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $120,000. The report was filed on Jan. 16, 2017.
Original Filing: 300846903.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010. USPSTF Approvals. Legislation on cancer screening test process.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Agency for Healthcare Research & Quality (AHRQ) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD) Office of Personnel Management (OPM)
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
21st century Cures project. Approval for cancer screening test. Interpretation of Section 2713 of the Affordable Care Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agency for Healthcare Research & Quality (AHRQ) Office of Personnel Management (OPM) Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2016
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on Oct. 19, 2016.
Original Filing: 300832400.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010. USPSTF Approvals. Legislation on cancer screening test process.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Agency for Healthcare Research & Quality (AHRQ) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD) Office of Personnel Management (OPM)
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
21st century Cures project. Approval for cancer screening test. Interpretation of Section 2713 of the Affordable Care Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agency for Healthcare Research & Quality (AHRQ) Office of Personnel Management (OPM) Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on July 15, 2016.
Original Filing: 300810552.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010. USPSTF Approvals. Legislation on cancer screening test process.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Agency for Healthcare Research & Quality (AHRQ) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD) Office of Personnel Management (OPM)
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
21st century Cures project. Approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agency for Healthcare Research & Quality (AHRQ) Office of Personnel Management (OPM) Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on April 17, 2016.
Original Filing: 300792595.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010. USPSTF Approvals. Legislation on cancer screening test process.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Agency for Healthcare Research & Quality (AHRQ) Centers For Medicare and Medicaid Services (CMS) Defense - Dept of (DOD) Office of Personnel Management (OPM)
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
21st century Cures project. Approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Agency for Healthcare Research & Quality (AHRQ) Office of Personnel Management (OPM) Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $80,000. The report was filed on Jan. 13, 2016.
Original Filing: 300771518.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010. USPSTF Approvals. Legislation on cancer screening test process.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
21st century Cures project. Approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on Oct. 15, 2015.
Original Filing: 300754263.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010. USPSTF Approvals.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
21st century Cures project. Approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2015
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $30,000. The report was filed on July 15, 2015.
Original Filing: 300735794.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
21st century Cures project. Approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2015
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $70,000. The report was filed on April 14, 2015.
Original Filing: 300715638.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection & Affordable Care Act. HR 4872 Recon Act 2010.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
21st century Cures project. Approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $80,000. The report was filed on Jan. 18, 2015.
Original Filing: 300699803.xml
Lobbying Issues
Health Care Reform--HR 3590, Patient Protection and Affordable Care Act. HR 4872.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Expedite FDA/CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
21st Century Cures project. Work on VA and Tricare acceptance of new technologies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2014
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $30,000. The report was filed on Oct. 11, 2014.
Original Filing: 300675326.xml
Lobbying Issues
Health Care Reform, HR 3590, Affordable Care Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 4872 Recon Act 2010 to expedite FDA/CMS approval process for cancer screening test.Twenty-first Century Cures project.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $30,000. The report was filed on July 17, 2014.
Original Filing: 300660379.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Expediting FDA/CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2014
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences . The report was filed on April 16, 2014.
Original Filing: 300637794.xml
Lobbying Issues
Health Care Reform. HR 3590 Patient Protection and Affordable Care
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4872 Reconciliation Act of 2010 to expedite FDA approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 4872--Reconciliation Act 2010 to expedite CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2013
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $20,000. The report was filed on Jan. 15, 2014.
Original Filing: 300615540.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FDA/CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 4872 Reconciliation Act 2010 to expedite FDA/CMS approval.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2013
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $10,000. The report was filed on Oct. 17, 2013.
Original Filing: 300597499.xml
Lobbying Issues
HR 4872 Recon Act 2010 to expedite FDA/CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 3590, Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2013
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $50,000. The report was filed on July 17, 2013.
Original Filing: 300574889.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient prof and aff care, HR 4872 Recon Act 2010 to expedite FDA/CMS approval process for cancer screening test,
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2013
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $30,000. The report was filed on April 16, 2013.
Original Filing: 300551206.xml
Lobbying Issues
Health Care Reform. HR 3590 Affordable Care Act. HR 4872.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Health Care Reform. HR 3590, HR 4872. Expedite FDA/CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
FDA/CMS approval process for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2012
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $20,000. The report was filed on Jan. 18, 2013.
Original Filing: 300535880.xml
Lobbying Issues
H&S approval to expedite FDA/CMS approval for cancer screening test.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
HR 4213 Tax extenders. Patient protection and affordable care reconciliation act 2010.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $10,000. The report was filed on Oct. 16, 2012.
Original Filing: 300508113.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant.
Agencies Lobbied
House of Representatives Senate
2nd Quarter, 2012
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $40,000. The report was filed on July 16, 2012.
Original Filing: 300485627.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant.
Agencies Lobbied
House of Representatives Senate
1st Quarter, 2012
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $40,000. The report was filed on April 12, 2012.
Original Filing: 300459615.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant.
Agencies Lobbied
House of Representatives Senate
4th Quarter, 2011
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $10,000. The report was filed on Jan. 13, 2012.
Original Filing: 300437382.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant.
Agencies Lobbied
House of Representatives Senate
3rd Quarter, 2011
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $20,000. The report was filed on Oct. 17, 2011.
Original Filing: 300415951.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant.
Agencies Lobbied
House of Representatives Senate
2nd Quarter, 2011
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $20,000. The report was filed on July 19, 2011.
Original Filing: 300398491.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant.
Agencies Lobbied
House of Representatives Senate
1st Quarter, 2011
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $10,000. The report was filed on April 6, 2011.
Original Filing: 300360446.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant
Agencies Lobbied
House of Representatives Senate
4th Quarter, 2010
BROYDRICK & ASSOCIATES amended a lobbying report for representation of Exact Sciences in Q42010 on Jan. 20, 2011.
Original Filing: 300349408.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant
Agencies Lobbied
House of Representatives Senate
4th Quarter, 2010
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $10,000. The report was filed on Jan. 14, 2011.
Original Filing: 300338059.xml
Lobbying Issues
HR 4213 Tax Extenders, Patient Protection and Affordable Care Act Reconciliation Act of 2010
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant
Agencies Lobbied
House of Representatives Senate
3rd Quarter, 2010
BROYDRICK & ASSOCIATES amended a lobbying report for representation of Exact Sciences in Q32010 on Oct. 15, 2010.
Original Filing: 300314393.xml
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health & Human Services Dept of (HHS) Internal Revenue Service (IRS)
Lobbying Issues
Qualified Therapeutic Discovery Tax Credit/Competitive Grant
Agencies Lobbied
House of Representatives Senate
2nd Quarter, 2010
In Q2, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $10,000. The report was filed on July 7, 2010.
Original Filing: 300282652.xml
Lobbying Issues
Tax Extenders HR 4213. HR 4872 Reconstruction Act 2010 to expedite FDA/CMS approval process for cancer screening test
Agencies Lobbied
House of Representatives Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2010
In Q1, BROYDRICK & ASSOCIATES lobbied for Exact Science . The report was filed on April 14, 2010.
Original Filing: 300257702.xml
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection and Affordable Care act, HR 4872 Reconstruction Act 2010 to expedite FDA/CMS approval process for cancer screening test
Agencies Lobbied
House of Representatives Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)
Lobbying Issues
Health Care Reform, HR 3590, Patient Protection and Affordable Care act, HR 4872 Reconstruction Act 2010 to expedite FDA/CMS approval process for cancer screening test
Agencies Lobbied
House of Representatives Senate Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2009
In Q4, BROYDRICK & ASSOCIATES lobbied for Exact Sciences , earning $20,000. The report was filed on Jan. 19, 2010.
Original Filing: 300239243.xml
Agencies Lobbied
House of Representatives Senate
3rd Quarter, 2009
In Q3, BROYDRICK & ASSOCIATES lobbied for Exact Sciences . The report was filed on Oct. 19, 2009.
Original Filing: 300212779.xml
Lobbying Issues
Medicare reimbursement, advocating medicare eligibility for testing
Agencies Lobbied
House of Representatives Senate
3rd Quarter, 2009
Broydrick & Associates filed a lobbying registration on Sept. 29, 2009 to represent Exact Sciences, effective Sept. 30, 2009.
Original Filing: 300199814.xml
Issue(s) they said they’d lobby about: Medicare reimbursement, advocating medicare eligibility for testing .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate